LACOSAMIDE
| Brand name | VIMPAT |
|---|---|
| Active ingredient | LACOSAMIDE |
| Strength | 200MG/20ML (10MG/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | October 2008 |
| Marketing status | RX |
| Code | Expires |
|---|---|
| D-188 | April 2026 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.